SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-11-003386
Filing Date
2011-06-24
Accepted
2011-06-24 19:20:59
Documents
1
Period of Report
2011-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 f4062211lapointe_soligenix.html 4  
1 FORM 4 f4062211lapointe_soligenix.xml 4 4074
  Complete submission text file 0001213900-11-003386.txt   5835
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9814 WASHINGTONIAN BLVD SUITE 500 GAITHERSBURG MD 20878
Business Address
LAPOINTE ANTHONY GREGG (Reporting) CIK: 0001331860 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 11931647